Risks

Longevity and mortality assumption shifts can pressure reserve adequacy and capital generation, but RGA’s global reinsurance scale and diversified book typically absorb shocks better than smaller peers.

Competitive pricing in life and health reinsurance can compress margins as cedants shop capacity, yet RGA’s breadth and underwriting depth generally support better retention than less diversified peers.

Higher interest-rate volatility can create mark-to-market and reinvestment noise, but RGA’s balance-sheet leverage remains moderate versus many financial peers, limiting downside transmission.

Regulatory and capital-rule changes across major markets can raise required capital and constrain deployment, though RGA’s multinational footprint usually provides more flexibility than regionally concentrated peers.

Opportunities

Persistently strong demand for longevity and mortality risk transfer supports new business flow, and RGA is well positioned versus peers with narrower product or geographic reach.

Higher-for-longer asset yields can lift reinvestment income and spread earnings, with RGA’s sizable in-force block better able to capture the benefit than smaller competitors.

Global pension de-risking and capital-management transactions remain structurally supportive, and RGA’s scale and underwriting reputation improve win rates versus mid-tier reinsurers.

Diversified international sourcing of business can offset weakness in any single market, giving RGA more stable growth visibility than peers concentrated in North America.

Overall Score

RGA’s forward positioning is strong because diversified reinsurance demand, scale, and moderate leverage support earnings resilience, while pricing and assumption risks remain manageable versus peers.